Investigating HLH Podcast Por Sobi Inc. arte de portada

Investigating HLH

Investigating HLH

De: Sobi Inc.
Escúchala gratis

Investigating HLH, brought to you by Sobi Inc., is a podcast that takes a deep dive into the complex world of hemophagocytic lymphohistiocytosis, or HLH. As a rare and fatal disease that was once considered incurable, HLH presents with a range of severe signs and symptoms that make diagnosis difficult. Join us as we discuss insights about HLH from all angles with various experts in the field of hematology-oncology who have helped to advance the understanding and treatment of this devastating disease. When treating patients with HLH, knowledge is power—because knowing what to look for can save lives.2023 Sobi Inc. Enfermedades Físicas Higiene y Vida Saludable
Episodios
  • What is MAS?

    What is MAS?
    Sep 23 2025

    In this episode of Investigating HLH, Adam Narloch speaks with Dr Daniella Schwartz and Dr Randy Cron to discuss a rare, potentially fatal syndrome characterized by hyperinflammation⎯macrophage activation syndrome (MAS). Dr Daniella Schwartz is a rheumatologist in Pittsburgh, Pennsylvania, and is affiliated with the University of Pittsburgh Medical Center (UPMC) Presbyterian Shadyside and the UPMC Magee-Womens Hospital. Dr Randy Cron is a pediatric rheumatologist at Children’s Hospital of Alabama at the University of Alabama (UAB). Hear from these 2 experts about MAS⎯a subtype of hemophagocytic lymphohistiocytosis (HLH) that can occur in rheumatic diseases such as SAll's disease, including systemic juvenile idiopathic arthritis (sJIA).

    Follow Us

    • YouTube @Sobi-Pharma
    • Linkedin @Sobi

    Presented by Sobi Inc.

    https://www.sobi.com/usa/en

    ©2023 Sobi, Inc. All rights reserved. NP-32204 12/23


    Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
    Más Menos
    30 m
  • Monitoring Treatment Response

    Monitoring Treatment Response
    Feb 25 2025

    Kari Magee speaks with Dr Bethany Verkamp to discuss her recent research on evaluating treatment response to etoposide-based treatment in patients with HLH. Dr Verkamp is a hematology/oncology fellow in the Cancer and Blood Diseases Institute at Cincinnati Children's Hospital. Hear from Dr Verkamp about her research, findings, and important considerations for assessing patient response to first-line etoposide-based HLH therapy.

    Follow Us

    • YouTube @Sobi-Pharma
    • Linkedin @Sobi

    Presented by Sobi Inc.

    https://www.sobi.com/usa/en

    ©2023 Sobi, Inc. All rights reserved. NP-32204 12/23

    Más Menos
    16 m
  • Treating HLH

    Treating HLH
    Jun 5 2024

    Adam Narloch is joined by Dr. Saara Kaviany and Dr. Blachy J. Dávila Saldaña for a discussion about treating patients with HLH. Dr Kaviany is a pediatric hematologist-oncologist and an assistant professor of pediatrics at University of Chicago Medicine. Dr Saldaña is also a pediatric hematologist-oncologist and an associate professor of pediatrics at George Washington University. Hear from these 2 experts about the overall treatment goals and strategies for patients with HLH.

    Follow Us

    • YouTube @Sobi-Pharma
    • Linkedin @Sobi

    Presented by Sobi Inc.

    www.sobi.com

    ©2023 Sobi, Inc. All rights reserved. NP-32204 12/23

    Más Menos
    36 m
Todavía no hay opiniones